Different Units By MoH Code
Revision Date : 11/01/2013
NovoSeven RT 100KIU MoH 5539 :
Form |
Powder and solvent for solution for injection |
Packaging |
Pre-filled Syringes + Vials (Type I glass) |
Package Size |
1+1 |
Strength |
2mg (100KIU) |
Public Price |
128495227,46 L.L. |
Stratum |
E2 |
NSSF |
✔ |
Quarantine |
✘ |
Reg. Number |
218018/09 |
Submission date |
01/01/2009 |
Registration Year |
2009 |
●
Country:
|
Italy
|
●
Package Size:
|
1+1x2.1ml
|
●
Public Price:
|
2158.24 EUR
|
( 39,668,559.11 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
2158,24 EUR
|
( 39,664,147.90 LBP )
|
●
Exfactory Price:
|
1307.7 EUR
|
●
Pricing Date:
|
17/12/2019
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Qatar
|
●
Package Size:
|
1
|
●
Public Price:
|
7927 QAR
|
( 32,901,489.12 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
7927 QAR
|
( 32,901,489.12 LBP )
|
●
Pharmacy Price:
|
6510.94417298 QAR
|
( 27024064.446604 LBP )
|
●
Pricing Date:
|
28/01/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Oman
|
●
Package Size:
|
1+1
|
●
Public Price:
|
834.57 OMR
|
( 32,799,018.29 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
834,57 OMR
|
( 32,776,617.00 LBP )
|
●
Pricing Date:
|
19/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Kuweit
|
●
Package Size:
|
1+1
|
●
Public Price:
|
638.4 KWD
|
( 31,645,539.07 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
638,4 KWD
|
( 31,625,711.04 LBP )
|
●
Pharmacy Price:
|
539.34 KWD
|
( 26735126.9472 LBP )
|
●
Pricing Date:
|
07/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Abu Dhabi
|
●
Package Size:
|
1+1x2.1ml
|
●
Public Price:
|
7406.5 AED
|
( 30,447,825.24 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
●
Pharmacy Price:
|
6309.52 AED
|
( 25938184.3392 LBP )
|
●
Pricing Date:
|
27/01/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
UAE
|
●
Package Size:
|
1 Vial (Powder) + 1 Solvent Vial (2.1ml)
|
●
Public Price:
|
7406.5 AED
|
( 30,447,825.24 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
●
Pharmacy Price:
|
6309.52 AED
|
( 25938184.3392 LBP )
|
●
Pricing Date:
|
21/08/2019
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Switzerland
|
●
Package Size:
|
1+1
|
●
Public Price:
|
1774.15 CHF
|
( 30,267,442.54 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1774,15 CHF
|
( 30,264,883.50 LBP )
|
●
Exfactory Price:
|
1690.88 CHF
|
●
Pricing Date:
|
04/04/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Finland
|
●
Package Size:
|
1+1x2ml
|
●
Public Price:
|
1579.45 EUR
|
( 29,030,369.97 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1579,45 EUR
|
( 29,022,098.95 LBP )
|
●
Reference:
|
Kela
|
●
Pricing Date:
|
22/04/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Bahrain
|
●
Package Size:
|
1+1
|
●
Public Price:
|
704.5 BHD
|
( 28,265,082.47 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
704,5 BHD
|
( 28,245,022.08 LBP )
|
●
Reference:
|
nhra
|
●
Pricing Date:
|
09/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Denmark
|
●
Package Size:
|
1+1
|
●
Public Price:
|
10629.4 DKK
|
( 26,158,634.52 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
10629,4 DKK
|
( 26,157,650.13 LBP )
|
●
Pharmacy Price:
|
7897.84 DKK
|
( 19436347.3048 LBP )
|
●
Reference:
|
Danish Medicine Agency
|
●
Pricing Date:
|
19/05/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Iceland
|
●
Package Size:
|
1+1
|
●
Public Price:
|
216970 ISK
|
( 24,053,294.20 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
216970 ISK
|
( 24,053,294.20 LBP )
|
●
Pharmacy Price:
|
169345 ISK
|
( 18773586.7 LBP )
|
●
Reference:
|
Icelandic Medicines Agency
|
●
Pricing Date:
|
01/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Czech Republic
|
●
Package Size:
|
1+1x2ml
|
●
Public Price:
|
34221.93 CZK
|
( 23,639,140.37 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
34221,93 CZK
|
( 23,638,497.96 LBP )
|
●
Reference:
|
SUKL
|
●
Pricing Date:
|
28/02/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Cyprus
|
●
Package Size:
|
1 x 2ml
|
●
Public Price:
|
1263.97 EUR
|
( 23,231,831.80 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1263,97 EUR
|
( 23,214,003.15 LBP )
|
●
Reference:
|
Cyprus Minister of Health
|
●
Pricing Date:
|
24/03/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Greece
|
●
Package Size:
|
1+1
|
●
Public Price:
|
1260.19 EUR
|
( 23,162,355.21 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1260,19 EUR
|
( 23,158,863.00 LBP )
|
●
Exfactory Price:
|
1115.49 EUR
|
●
Pharmacy Price:
|
1132.25 EUR
|
( 20810811.6125 LBP )
|
●
Reference:
|
National Organization for Medicines
|
●
Pricing Date:
|
25/02/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Spain
|
●
Package Size:
|
1 vial + 1xdisolvente
|
●
Public Price:
|
1220.48 EUR
|
( 22,432,483.42 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1220,48 EUR
|
( 22,423,661.00 LBP )
|
●
Reference:
|
Agencia Española de Medicamentos y Productos Sanitarios
|
●
Pricing Date:
|
06/05/2021
|
●
Type:
|
Medicine Non Marketed
|
●
Country:
|
France
|
●
Package Size:
|
1+1
|
●
Public Price:
|
1216 EUR
|
( 22,350,140.80 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1216 EUR
|
( 22,350,140.80 LBP )
|
●
Reference:
|
ansm
|
●
Pricing Date:
|
15/05/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
KSA
|
●
Package Size:
|
2mg
|
●
Public Price:
|
5290.4 SAR
|
( 21,322,322.35 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
5290,4 SAR
|
( 21,320,710.20 LBP )
|
●
Reference:
|
sfda
|
●
Pricing Date:
|
16/01/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
UK
|
●
Package Size:
|
1+1
|
●
Public Price:
|
1050.4 GBP
|
( 21,166,368.81 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1050,4 GBP
|
( 21,158,308.50 LBP )
|
●
Reference:
|
DMD
|
●
Pricing Date:
|
08/03/2021
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Norway
|
●
Package Size:
|
1
|
●
Public Price:
|
12060.5 NOK
|
( 20,867,921.34 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
12060,5 NOK
|
( 20,867,056.20 LBP )
|
●
Pharmacy Price:
|
9430.82 NOK
|
( 16317864.9214 LBP )
|
●
Reference:
|
Norwegian Medicine Agency
|
●
Pricing Date:
|
01/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Sweden
|
●
Package Size:
|
1+1
|
●
Public Price:
|
11420.85 SEK
|
( 20,558,786.29 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
11420,85 SEK
|
( 20,557,256.20 LBP )
|
●
Pharmacy Price:
|
11151.57 SEK
|
( 20074052.6727 LBP )
|
●
Pricing Date:
|
23/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Belgium
|
●
Package Size:
|
1+1x2.1ml
|
●
Public Price:
|
1065 EUR
|
( 19,574,753.25 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
1065 EUR
|
( 19,574,753.25 LBP )
|
●
Reference:
|
cbip
|
●
Pricing Date:
|
02/12/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Turkey
|
●
Package Size:
|
1
|
●
Public Price:
|
5801.16 TRY
|
( 11,142,230.00 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
5801,16 TRY
|
( 11,141,922.69 LBP )
|
●
Pricing Date:
|
28/10/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Lebanon
|
●
Form:
|
Powder and solvent for solution for injection
|
●
Package Size:
|
1+1
|
●
Public Price:
|
2095926 LBP
|
( 2,095,926.00 LBP )
|
●
Pack size unit used:
|
1
|
●
Cost/Unit:
|
2095926 LBP
|
( 2,095,926.00 LBP )
|
●
Pricing Date:
|
10/01/2024
|
●
Country:
|
The Netherlands
|
●
Package Size:
|
1
|
●
Reference:
|
Zorginstituut Nederland
|
●
Pricing Date:
|
15/06/2019
|
●
Type:
|
Medicine Non Marketed
|
●
Country:
|
New Zealand
|
●
Package Size:
|
1 inj
|
●
Exfactory Price:
|
2356.6 NZD
|
●
Reference:
|
New Zealand Pharmaceutical Management Agency
|
●
Pricing Date:
|
01/04/2020
|
●
Type:
|
Medicine Authorised
|
●
Country:
|
Portugal
|
●
Package Size:
|
1+1
|
●
Reference:
|
Autoridade Nacional do Medicamento e Produtos de Saúde
|
●
Pricing Date:
|
22/04/2019
|
Acquired haemophilia :
●
Cost/Unit:
|
2158,24 EUR
|
( 39,664,147.90 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
2158,24 EUR
|
( 39,664,147.90 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
2158,24 EUR
|
( 39,664,147.90 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
2158,24 EUR
|
( 39,664,147.90 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
2158,24 EUR
|
( 39,664,147.90 LBP )
|
● Cost/Day:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
●
Cost/Month:
|
6474,72 EUR
|
( 118,992,443.70 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
7927 QAR
|
( 32,901,489.12 LBP )
|
● Cost/Day:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
●
Cost/Month:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
7927 QAR
|
( 32,901,489.12 LBP )
|
● Cost/Day:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
●
Cost/Month:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
7927 QAR
|
( 32,901,489.12 LBP )
|
● Cost/Day:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
●
Cost/Month:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
7927 QAR
|
( 32,901,489.12 LBP )
|
● Cost/Day:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
●
Cost/Month:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
7927 QAR
|
( 32,901,489.12 LBP )
|
● Cost/Day:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
●
Cost/Month:
|
23781 QAR
|
( 98,704,467.36 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
834,57 OMR
|
( 32,776,617.00 LBP )
|
● Cost/Day:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
834,57 OMR
|
( 32,776,617.00 LBP )
|
● Cost/Day:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
834,57 OMR
|
( 32,776,617.00 LBP )
|
● Cost/Day:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
834,57 OMR
|
( 32,776,617.00 LBP )
|
● Cost/Day:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
834,57 OMR
|
( 32,776,617.00 LBP )
|
● Cost/Day:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
●
Cost/Month:
|
2503,71 OMR
|
( 98,369,151.50 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
638,4 KWD
|
( 31,625,711.04 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
638,4 KWD
|
( 31,625,711.04 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
638,4 KWD
|
( 31,625,711.04 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
638,4 KWD
|
( 31,625,711.04 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
638,4 KWD
|
( 31,625,711.04 LBP )
|
● Cost/Day:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
●
Cost/Month:
|
1915,2 KWD
|
( 94,926,703.20 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
7406,5 AED
|
( 30,445,769.76 LBP )
|
● Cost/Day:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
●
Cost/Month:
|
22219,5 AED
|
( 91,341,420.24 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1774,15 CHF
|
( 30,264,883.50 LBP )
|
● Cost/Day:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
●
Cost/Month:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1774,15 CHF
|
( 30,264,883.50 LBP )
|
● Cost/Day:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
●
Cost/Month:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1774,15 CHF
|
( 30,264,883.50 LBP )
|
● Cost/Day:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
●
Cost/Month:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1774,15 CHF
|
( 30,264,883.50 LBP )
|
● Cost/Day:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
●
Cost/Month:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1774,15 CHF
|
( 30,264,883.50 LBP )
|
● Cost/Day:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
●
Cost/Month:
|
5322,45 CHF
|
( 90,794,650.50 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1579,45 EUR
|
( 29,022,098.95 LBP )
|
● Cost/Day:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
●
Cost/Month:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1579,45 EUR
|
( 29,022,098.95 LBP )
|
● Cost/Day:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
●
Cost/Month:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1579,45 EUR
|
( 29,022,098.95 LBP )
|
● Cost/Day:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
●
Cost/Month:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1579,45 EUR
|
( 29,022,098.95 LBP )
|
● Cost/Day:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
●
Cost/Month:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1579,45 EUR
|
( 29,022,098.95 LBP )
|
● Cost/Day:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
●
Cost/Month:
|
4738,35 EUR
|
( 87,084,676.90 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
704,5 BHD
|
( 28,245,022.08 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
704,5 BHD
|
( 28,245,022.08 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
704,5 BHD
|
( 28,245,022.08 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
704,5 BHD
|
( 28,245,022.08 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
704,5 BHD
|
( 28,245,022.08 LBP )
|
● Cost/Day:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
●
Cost/Month:
|
2113,5 BHD
|
( 84,775,187.01 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
10629,4 DKK
|
( 26,157,650.13 LBP )
|
● Cost/Day:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
●
Cost/Month:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
10629,4 DKK
|
( 26,157,650.13 LBP )
|
● Cost/Day:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
●
Cost/Month:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
10629,4 DKK
|
( 26,157,650.13 LBP )
|
● Cost/Day:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
●
Cost/Month:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
10629,4 DKK
|
( 26,157,650.13 LBP )
|
● Cost/Day:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
●
Cost/Month:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
10629,4 DKK
|
( 26,157,650.13 LBP )
|
● Cost/Day:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
●
Cost/Month:
|
31888,2 DKK
|
( 78,475,411.36 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
216970 ISK
|
( 24,053,294.20 LBP )
|
● Cost/Day:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
●
Cost/Month:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
216970 ISK
|
( 24,053,294.20 LBP )
|
● Cost/Day:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
●
Cost/Month:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
216970 ISK
|
( 24,053,294.20 LBP )
|
● Cost/Day:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
●
Cost/Month:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
216970 ISK
|
( 24,053,294.20 LBP )
|
● Cost/Day:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
●
Cost/Month:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
216970 ISK
|
( 24,053,294.20 LBP )
|
● Cost/Day:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
●
Cost/Month:
|
650910 ISK
|
( 72,159,882.60 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
34221,93 CZK
|
( 23,638,497.96 LBP )
|
● Cost/Day:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
●
Cost/Month:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
34221,93 CZK
|
( 23,638,497.96 LBP )
|
● Cost/Day:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
●
Cost/Month:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
34221,93 CZK
|
( 23,638,497.96 LBP )
|
● Cost/Day:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
●
Cost/Month:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
34221,93 CZK
|
( 23,638,497.96 LBP )
|
● Cost/Day:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
●
Cost/Month:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
34221,93 CZK
|
( 23,638,497.96 LBP )
|
● Cost/Day:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
●
Cost/Month:
|
102665,79 CZK
|
( 70,916,875.40 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1263,97 EUR
|
( 23,214,003.15 LBP )
|
● Cost/Day:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
●
Cost/Month:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1263,97 EUR
|
( 23,214,003.15 LBP )
|
● Cost/Day:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
●
Cost/Month:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1263,97 EUR
|
( 23,214,003.15 LBP )
|
● Cost/Day:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
●
Cost/Month:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1263,97 EUR
|
( 23,214,003.15 LBP )
|
● Cost/Day:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
●
Cost/Month:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1263,97 EUR
|
( 23,214,003.15 LBP )
|
● Cost/Day:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
●
Cost/Month:
|
3791,91 EUR
|
( 69,678,769.55 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1260,19 EUR
|
( 23,158,863.00 LBP )
|
● Cost/Day:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
●
Cost/Month:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1260,19 EUR
|
( 23,158,863.00 LBP )
|
● Cost/Day:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
●
Cost/Month:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1260,19 EUR
|
( 23,158,863.00 LBP )
|
● Cost/Day:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
●
Cost/Month:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1260,19 EUR
|
( 23,158,863.00 LBP )
|
● Cost/Day:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
●
Cost/Month:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1260,19 EUR
|
( 23,158,863.00 LBP )
|
● Cost/Day:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
●
Cost/Month:
|
3780,57 EUR
|
( 69,476,589.00 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1220,48 EUR
|
( 22,423,661.00 LBP )
|
● Cost/Day:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
●
Cost/Month:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1220,48 EUR
|
( 22,423,661.00 LBP )
|
● Cost/Day:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
●
Cost/Month:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1220,48 EUR
|
( 22,423,661.00 LBP )
|
● Cost/Day:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
●
Cost/Month:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1220,48 EUR
|
( 22,423,661.00 LBP )
|
● Cost/Day:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
●
Cost/Month:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1220,48 EUR
|
( 22,423,661.00 LBP )
|
● Cost/Day:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
●
Cost/Month:
|
3661,44 EUR
|
( 67,289,363.05 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1216 EUR
|
( 22,350,140.80 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1216 EUR
|
( 22,350,140.80 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1216 EUR
|
( 22,350,140.80 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1216 EUR
|
( 22,350,140.80 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1216 EUR
|
( 22,350,140.80 LBP )
|
● Cost/Day:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
●
Cost/Month:
|
3648 EUR
|
( 67,050,422.40 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
5290,4 SAR
|
( 21,320,710.20 LBP )
|
● Cost/Day:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
●
Cost/Month:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
5290,4 SAR
|
( 21,320,710.20 LBP )
|
● Cost/Day:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
●
Cost/Month:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
5290,4 SAR
|
( 21,320,710.20 LBP )
|
● Cost/Day:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
●
Cost/Month:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
5290,4 SAR
|
( 21,320,710.20 LBP )
|
● Cost/Day:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
●
Cost/Month:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
5290,4 SAR
|
( 21,320,710.20 LBP )
|
● Cost/Day:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
●
Cost/Month:
|
15871,2 SAR
|
( 63,966,160.98 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1050,4 GBP
|
( 21,158,308.50 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1050,4 GBP
|
( 21,158,308.50 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1050,4 GBP
|
( 21,158,308.50 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1050,4 GBP
|
( 21,158,308.50 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1050,4 GBP
|
( 21,158,308.50 LBP )
|
● Cost/Day:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
●
Cost/Month:
|
3151,2 GBP
|
( 63,495,076.27 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
12060,5 NOK
|
( 20,867,056.20 LBP )
|
● Cost/Day:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
●
Cost/Month:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
12060,5 NOK
|
( 20,867,056.20 LBP )
|
● Cost/Day:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
●
Cost/Month:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
12060,5 NOK
|
( 20,867,056.20 LBP )
|
● Cost/Day:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
●
Cost/Month:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
12060,5 NOK
|
( 20,867,056.20 LBP )
|
● Cost/Day:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
●
Cost/Month:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
12060,5 NOK
|
( 20,867,056.20 LBP )
|
● Cost/Day:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
●
Cost/Month:
|
36181,5 NOK
|
( 62,602,898.87 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
11420,85 SEK
|
( 20,557,256.20 LBP )
|
● Cost/Day:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
●
Cost/Month:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
11420,85 SEK
|
( 20,557,256.20 LBP )
|
● Cost/Day:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
●
Cost/Month:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
11420,85 SEK
|
( 20,557,256.20 LBP )
|
● Cost/Day:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
●
Cost/Month:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
11420,85 SEK
|
( 20,557,256.20 LBP )
|
● Cost/Day:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
●
Cost/Month:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
11420,85 SEK
|
( 20,557,256.20 LBP )
|
● Cost/Day:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
●
Cost/Month:
|
34262,55 SEK
|
( 61,675,368.82 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
1065 EUR
|
( 19,574,753.25 LBP )
|
● Cost/Day:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
●
Cost/Month:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
1065 EUR
|
( 19,574,753.25 LBP )
|
● Cost/Day:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
●
Cost/Month:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
1065 EUR
|
( 19,574,753.25 LBP )
|
● Cost/Day:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
●
Cost/Month:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
1065 EUR
|
( 19,574,753.25 LBP )
|
● Cost/Day:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
●
Cost/Month:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
1065 EUR
|
( 19,574,753.25 LBP )
|
● Cost/Day:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
●
Cost/Month:
|
3195 EUR
|
( 58,724,259.75 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
5801,16 TRY
|
( 11,141,922.69 LBP )
|
● Cost/Day:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
●
Cost/Month:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
5801,16 TRY
|
( 11,141,922.69 LBP )
|
● Cost/Day:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
●
Cost/Month:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
5801,16 TRY
|
( 11,141,922.69 LBP )
|
● Cost/Day:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
●
Cost/Month:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
5801,16 TRY
|
( 11,141,922.69 LBP )
|
● Cost/Day:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
●
Cost/Month:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
5801,16 TRY
|
( 11,141,922.69 LBP )
|
● Cost/Day:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
●
Cost/Month:
|
17403,48 TRY
|
( 33,425,768.07 LBP )
|
Acquired haemophilia :
●
Cost/Unit:
|
2095926 LBP
|
( 2,095,926.00 LBP )
|
● Cost/Day:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
●
Cost/Month:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
Congenital FVII deficiency :
●
Cost/Unit:
|
2095926 LBP
|
( 2,095,926.00 LBP )
|
● Cost/Day:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
●
Cost/Month:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors IX :
●
Cost/Unit:
|
2095926 LBP
|
( 2,095,926.00 LBP )
|
● Cost/Day:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
●
Cost/Month:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
Congenital haemophilia with inhibitors to coagulation factors VIII :
●
Cost/Unit:
|
2095926 LBP
|
( 2,095,926.00 LBP )
|
● Cost/Day:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
●
Cost/Month:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA :
(Adults)
●
Cost/Unit:
|
2095926 LBP
|
( 2,095,926.00 LBP )
|
● Cost/Day:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
●
Cost/Month:
|
6287778 LBP
|
( 6,287,778.00 LBP )
|
Prices are provided in Dollar ($)
You have to register to view this info
You have to register to view this info